|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/08 | |
| A61K 31/55 | |||
| A61K 9/00 | |||
| A61P 35/00 |
| (11) | Number of the document | 2459173 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10739413.2 |
| Date of filing the European patent application | 2010-07-28 | |
| (97) | Date of publication of the European application | 2012-06-06 |
| (45) | Date of publication and mention of the grant of the patent | 2018-02-28 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2010/002109 |
| Date | 2010-07-28 |
| (87) | Number | WO 2011/014248 |
| Date | 2011-02-03 |
| (30) | Number | Date | Country code |
| 230212 P | 2009-07-31 | US |
| (72) |
RAMANAN, Vijayalakshmi, US
TOBIAS, Irene Sophie, US
VERWIJS, Dauntel Specht, US
SKWIERCZYNSKI, Raymond D., US
|
| (73) |
Millennium Pharmaceuticals, Inc.,
40 Landsdowne Street, Cambridge, MA 02139,
US
|
| (54) | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CANCER AND OTHER DISEASES OR DISORDERS |
| PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CANCER AND OTHER DISEASES OR DISORDERS |